Archil Jaliashvili: NATO Blood Panel Warns That The System Won’t Hold Under Real Surge Conditions
Archil Jaliashvili, Co-owner, General Manager of SkinAI, Co-Chief Executive Officer at GeoBio Pharm, shared a post on LinkedIn about a recent article by Nadira Frescalinea et al, published in The Lancet:
”Blood is not just a medical resource.
It’s infrastructure. It’s strategy. It’s sovereignty.
The warning from the NATO Blood Panel (via AABB, The Lancet) is clear:
The system won’t hold under real surge conditions.
- Reality
- 42-day shelf life
- Cold chain dependency
- Fragile logistics
Works in hospitals. Fails in disruption.
- Where it matters most
- Pre-hospital
- Battlefield
- Accidents
- Early transfusion equals survival
The gap:
It’s not donors.
It’s function delivery under pressure.
BHOC – what we believe
BHOC – Biological Hemoglobin Oxygen Carrier can fill the gap:
- Restore blood oxygenation immediately
- Controlled oxygen delivery
- Low-risk side effects
- No blood typing, no cold chain
- Rapid deployment where it matters most
Early oxygen delivery saves lives.
Top of that
What’s your opinion why we transfuse blood ?
What we treat ? How we define needs and outcome ?
Drop your idea, thought , share your opinion”
Title: Call to enhance civilian and military blood preparedness
Authors: Nadira Frescalinea, Andrew Beckett, Michael C Reade
Read the Full Article on The Lancet
Stay updated on all scientific advances with Hemostasis Today.
-
May 6, 2026, 12:12Mona Ranade: Insights from a Medeloop Analytics Study Evaluate Catheter-Directed Therapy in Pulmonary Embolism
-
May 6, 2026, 11:50Natalie L. Baggio: A 24/7 Neurointerventional Stroke Care at Corewell Health Is Now a Reality
-
May 6, 2026, 11:30Paula Caporal: Consensus on the Diagnosis and Management of Pediatric Stroke in Argentina
-
May 6, 2026, 11:14Li Khim Kwah: Proud for the Development of The New Singapore Stroke Rehabilitation Guideline
-
May 6, 2026, 10:55Hugo Antonio Romo Rubio: A New Paradigm in Treatment for Hemophilia A from FRONTIERS2 Phase 3 Study
-
May 6, 2026, 10:40Ifeanyichukwu Ifechidere: Why INR Can Be Dangerously Misleading
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Connecting with so Many Families and Advocates at HFA 2026
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?